EPISODE · May 19, 2026 · 6 MIN
Battle for Lightweight Championship! Tirzepatide vs Semaglutide Head to Head for Weight Loss
from Dispense As Written · host Gregory Castelli
Title: Tirzepatide vs Semaglutide: Which GLP-1 Wins? | SURMOUNT-5 TrialDescription:Head-to-head comparison: tirzepatide 15mg vs semaglutide 2.4mg for weight loss. SURMOUNT-5 trial breakdown in under 5 minutes. Evidence-based medicine, no fluff.📊 KEY FINDINGS:Tirzepatide: -20.2% weight loss at 72 weeksSemaglutide: -13.7% weight loss at 72 weeks48.4% vs 27.3% achieving ≥20% weight lossSimilar tolerability (6.1% vs 8.0% discontinuations)Tirzepatide superior for weight reduction📚 CITATION:Aronne LJ, Horn DB, le Roux CW, et al. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity. N Engl J Med. 2025;393:26-36.DOI: 10.1056/NEJMoa2416394🎓 ABOUT:Gregory Castelli, PharmD, FCCP, BCPS, BC-ADM, CDCESAssociate ProfessorDirector of Academic and Clinical PharmacyEditor-in-Chief, PURL SeriesDispense As Written delivers evidence-based medicine for busy clinicians—without the fluff.
Embed this episode
NOW PLAYING
Battle for Lightweight Championship! Tirzepatide vs Semaglutide Head to Head for Weight Loss
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.